Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.

Ohman EM, Granger CB, Rice L, Abrams CS, Becker RC, Berger PB, Kleiman NS, Moliterno D, Moll S, Rodgers JE, Steinhubl SS, Tapson VF, Sinnaeve P, Anstrom KJ; Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry..

J Thromb Thrombolysis. 2005 Feb;19(1):11-9.

PMID:
15976962
2.

Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.

Crespo EM, Oliveira GB, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Granger CB, Ohman EM; CATCH Registry Investigators..

Am Heart J. 2009 Apr;157(4):651-7. doi: 10.1016/j.ahj.2009.01.005. Epub 2009 Mar 17.

PMID:
19332191
3.

Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution.

Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S.

Am J Hematol. 1997 Sep;56(1):12-6. Erratum in: Am J Hematol 1998 Jul;58(3):253.

4.

Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.

Baroletti S, Piovella C, Fanikos J, Labreche M, Lin J, Goldhaber SZ.

Thromb Haemost. 2008 Dec;100(6):1130-5.

PMID:
19132240
5.
6.

Heparin-induced thrombocytopenia.

Fabris F, Luzzatto G, Stefani PM, Girolami B, Cella G, Girolami A.

Haematologica. 2000 Jan;85(1):72-81. Review.

7.

Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients.

Hourigan LA, Walters DL, Keck SA, Dec GW.

J Heart Lung Transplant. 2002 Dec;21(12):1283-9.

PMID:
12490273
8.

[Postoperative heparin-induced thrombopenia with thromboembolism (HITT)--a rare complication of heparin therapy?].

Goti F, Gianom D, Korte W, Sege D, Decurtins M.

Swiss Surg. 2001;7(2):51-6. German.

PMID:
11332264
9.

Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.

Ban-Hoefen M, Francis C.

Thromb Res. 2009 Jun;124(2):189-92. doi: 10.1016/j.thromres.2009.01.006. Epub 2009 Feb 4.

PMID:
19195684
10.

Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases.

Kappers-Klunne MC, Boon DM, Hop WC, Michiels JJ, Stibbe J, van der Zwaan C, Koudstaal PJ, van Vliet HH.

Br J Haematol. 1997 Mar;96(3):442-6.

PMID:
9054645
11.

Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.

Randi ML, Tezza F, Scapin M, Duner E, Scarparo P, Scandellari R, Fabris F.

Acta Haematol. 2010;123(3):140-5. doi: 10.1159/000280466. Epub 2010 Feb 4.

PMID:
20134155
13.

Heparin: induced thrombocytopenia: incidence and laboratory approach to diagnosis in Indians.

Kotwal J, Chaudhary S, Manoj MG, Hasnain S, Nair V, Luthra M.

Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):31-8. doi: 10.4103/0377-4929.130886.

14.

Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients.

Schmugge M, Risch L, Huber AR, Benn A, Fischer JE.

Pediatrics. 2002 Jan;109(1):E10.

PMID:
11773578
15.

Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.

Walenga JM, Jeske WP, Messmore HL.

J Thromb Thrombolysis. 2000 Nov;10 Suppl 1:13-20. Review.

PMID:
11155190
16.

Heparin-induced thrombocytopenia, a prothrombotic disease.

Levy JH, Hursting MJ.

Hematol Oncol Clin North Am. 2007 Feb;21(1):65-88. Review.

PMID:
17258119
17.

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.

Girolami B, Prandoni P, Stefani PM, Tanduo C, Sabbion P, Eichler P, Ramon R, Baggio G, Fabris F, Girolami A.

Blood. 2003 Apr 15;101(8):2955-9. Epub 2002 Dec 12.

18.

Heparin-induced thrombocytopenia in intensive care patients.

Selleng K, Selleng S, Greinacher A.

Semin Thromb Hemost. 2008 Jul;34(5):425-38. doi: 10.1055/s-0028-1092872. Epub 2008 Oct 27. Review.

PMID:
18956282
19.

The direct medical costs associated with suspected heparin-induced thrombocytopenia.

Nanwa N, Mittmann N, Knowles S, Bucci C, Selby R, Shear N, Walker SE, Geerts W.

Pharmacoeconomics. 2011 Jun;29(6):511-20. doi: 10.2165/11584330-000000000-00000.

PMID:
21473656
20.

Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).

Lopes RD, Ohman EM, Granger CB, Honeycutt EF, Anstrom KJ, Berger PB, Crespo EM, Oliveira GB, Moll S, Moliterno DJ, Abrams CS, Becker RC.

Am J Cardiol. 2009 Nov 1;104(9):1285-91. doi: 10.1016/j.amjcard.2009.06.045.

PMID:
19840578

Supplemental Content

Support Center